Abstract
The studies related to the impact of clinical pharmacist intervention in the drug-related problem are lacking. Therefore, the aim of this study was to assess the clinical pharmacist interventions and probable impact of these interventions in cost minimization by reducing direct medication costs at a specialized cardiac center in Saudi Arabia. This was a retrospective observational study conducted at Prince Sultan Cardiac Center (PSCC) in Riyadh, Saudi Arabia. A total number of 18,480 clinical pharmacist interventions were recorded between January 2011 and December 2013. The 3 highest causes of clinical pharmacy interventions included 25.4% for disease management, 20.5% for pharmacokinetic and dose monitoring, and 10.4% for drug discontinuation. Total cost reduced after clinical pharmacy interventions were SAR 437,805 (US$ 116,748) during the period of the study. Our study could demonstrate that the participation of a clinical pharmacist during ward rounds is very helpful for the optimization of pharmacotherapy.